NCT04072393 2024-07-12
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
Washington University School of Medicine
Phase NA Terminated
Clinical Trials
12 trialsNCT04925947 2024-04-16
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
Weill Medical College of Cornell University
Phase 2 Terminated
NCT04469725 2024-03-12
KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Terminated
NCT03193437 2023-02-16
SELECT
Georgetown University
Phase 2 Terminated
NCT01143545 2020-03-03
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01258868 2019-12-03
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT02062632 2019-10-01
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Mayo Clinic
Phase 2 Terminated
NCT01011439 2019-02-06
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT01301391 2019-02-06
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT01100944 2017-08-10
A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT00718809 2015-06-10
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00818090 2013-04-12
Paclitaxel and Cisplatin for Thymic Neoplasm
Korean Cancer Study Group
Phase 2 Terminated